Dianthus Therapeutics, Inc. Common Stock (DNTH) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for DNTH. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 4,123,822 | $402M | INCREASED |
| State Street | 2,357,440 | $230M | INCREASED |
| Jennison Associates | 1,021,763 | $100M | INCREASED |
| Assenagon Asset Management | 280,649 | $27M | NEW |
| BNY Mellon | 256,393 | $25M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Marino Garcia (CEO AND PRESIDENT) | EXERCISE | 126,000 | $1M | 2026-08-07 |
| Marino Garcia (CEO AND PRESIDENT) | EXERCISE | 40,000 | $338K | 2026-08-07 |
| Marino Garcia (CEO AND PRESIDENT) | SELL | 21,909 | $2M | 2026-08-07 |
| Marino Garcia (CEO AND PRESIDENT) | SELL | 104,091 | $11M | 2026-08-07 |
| Marino Garcia (CEO AND PRESIDENT) | SELL | 800 | $89K | 2026-08-07 |
Full institutional holdings, insider history, and congressional trades for Dianthus Therapeutics, Inc. Common Stock on SentiSense.